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Embryonic pluripotency can be recapitulated in vitro by a spectrum of pluripotent stem cell states stabilized
with different culture conditions. Their distinct spatiotemporal characteristics provide an unprecedented tool
for the study of early human development. The newly unveiled ability of some stem cell types for crossing
xeno-barriers will facilitate the generation of interspecies chimeric embryos from distant species, including
humans. When combined with efficient zygote genome editing technologies, xenogeneic human pluripotent
stem cells may also open new frontiers for regenerative medicine applications, including the possibility of
generating human organs in animals via interspecies chimeric complementation.Introduction
Following a precisely choreographed and spatiotemporally
controlled developmental program, pluripotent cells, which are
initially contained in the embryonic epiblast, can give rise to all
cell lineages of the developing and adult organism. Embryonic
pluripotency is short lived but can be captured in vitro under arti-
ficial culture conditions. Unlike the epiblast, pluripotent cells in
culture can self-renew indefinitely while retaining multilineage
differentiation abilities. Pluripotency can also be reinstated in
cells of later developmental stages through culture adaptation
(e.g., embryonic germ cells) (Matsui et al., 1992; Resnick et al.,
1992), somatic cell nuclear transfer (SCNT) (Gurdon, 1962; Wil-
mut et al., 2002), or cellular reprogramming with defined tran-
scription factors (iPSCs) (Takahashi and Yamanaka, 2006).
These artificially converted pluripotent cells exhibit molecular
and functional properties similar to and characteristic of the em-
bryonic epiblast. Additionally, recent studies have introduced a
new twist by unveiling subtle but functionally important, molecu-
lar differences among stem cells from distinct temporal and
spatial domains within the epiblast (Hackett and Surani, 2014;
Kojima et al., 2014; Nichols and Smith, 2009; Wu et al., 2015).
Thanks to these and other observations, our understanding of
pluripotency has been greatly broadened in the past decade.
Pluripotency, as we see it today, is no longer a singular property.
The recent discovery of distinct spatiotemporal pluripotent
states has brought us one step closer to grasping the essence
of how the intrinsic developmental program is orchestrated
among ephemeral epiblast cells in preparation for setting up
the whole body plan. Moreover, discrete pluripotent states with
uniquemolecular and functional features have expanded the util-
ity of pluripotent stem cells (PSCs) for both fundamental and clin-
ical research.
In this Perspective, we will provide a brief account of the
distinct pluripotent states identified to date in both rodents and
primates, their molecular features, functional properties, and po-
tential applications. To build upon these insights, we also pro-
pose the concept of xeno-pluripotency, which we define as the
capability of PSCs from one species to enter into the early em-
bryonic developmental program of another species and
contribute to chimera formation. Finally, we summarize previouswork on interspecies chimeras and elaborate on an emerging
application, interspecies chimeric complementation, for regen-
erative medicine applications.
Naive and Primed Pluripotent States
Mouse ESCs (mESCs) were the first pluripotent cell type isolated
from early embryos. In 1981, Evans and Kaufman (1981) and Gail
R. Martin (Martin, 1981) independently reported the successful
establishment of cultured ESC lines from mouse blastocysts.
mESCs were first grown on mitotically inactivated feeder cells
in the presence of serum. Later studies identified LIF and
BMP4 to be sufficient to liberate mESCs from serum and feeders
without compromising their chimeric and germline competency
(Smith et al., 1988; Ying et al., 2003). Further refinements led to
the establishment of the ground state culture: a minimal condi-
tion devoid of extrinsic stimuli and only containing two small
molecule inhibitors (2i): a GSK3 inhibitor, CHIR99021, which ac-
tivates the canonical Wnt pathway and promotes self-renewal,
and a MEK inhibitor, PD0325901, which blocks differentiation
(Ying et al., 2008). 2i culture supports robust derivation, propa-
gation, and pluripotency of mESCs from a variety of genetic
backgrounds, including non-permissive strains, which are resis-
tant to ESCderivation using conventional cultures (Kawase et al.,
1994). More importantly, 2i culture also supports the derivation
of authentic ESCs from rat blastocysts, a feat achieved 27 years
after the initial mESC derivation (Buehr et al., 2008; Li et al.,
2008). These milestone studies of rodent ESCs paved the way
toward the derivation of ESCs from other species, including
humans.
Since the initial reports of mESCs, derivation of ESC lines has
been attempted in several non-rodent species with limited suc-
cess (Chen et al., 1999; Evans et al., 1990). These putative
ESCs could generate tissues representative of all three germ lin-
eages in culture; however, their developmental potential wasn’t
evaluated using in vivo assays. In 1995, the derivation of the first
stable ESC line from a primate, the rhesus macaque, was re-
ported (Thomson et al., 1995), observations which ultimately
led to the successful derivation of ESCs from human blastocysts
(hESCs) (Ludwig et al., 2006; Reubinoff et al., 2000; Thomson
et al., 1998). Despite similar embryonic origins, there are severalCell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc. 509
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ony morphology of mESCs is ‘‘dome’’ shaped, while hESCs
appear flattened; (2) some signature pluripotent markers differ
between human and mouse ESCs; e.g., hESCs express
SSEA-3 and SSEA-4 instead of SSEA-1, which are expressed
by mESCs; and (3) unlike mESCs, hESCs are sensitive to sin-
gle-cell dissociation and thus need to be passaged as small
clumps. Signaling pathways involved in the maintenance of the
human andmouse ESCpluripotency programs are also different:
instead of LIF/BMP4, hESCs are dependent on FGF/TGFb
signaling pathways for their maintenance in an undifferentiated
state (Vallier et al., 2005). These differences were initially attrib-
uted to the divergent pre-implantation developmental programs
between primate and rodent. This notion, however, was chal-
lenged when another pluripotent cell line designated as epiblast
stem cells (EpiSCs) was derived from the post-implantation
mouse epiblast (Brons et al., 2007; Tesar et al., 2007). EpiSCs
exhibit features resembling the salient characteristics of hESCs
including colony morphology, low single-cell cloning efficiency,
and signaling dependency, among others. Notably, like hESCs,
EpiSCs could also be obtained directly from pre-implantation
blastocysts (Najm et al., 2011). The similarities shared between
hESCs and EpiSCs suggest that, during derivation, isolated hu-
man inner cell mass (ICM) likely continued on their develop-
mental trajectory in culture to a developmentally more advanced
state and acquired an EpiSC-like identity. In support of this
notion, Sutter and colleagues identified a transient post-ICM in-
termediate (PICMI) during the transition from human ICM to
ESCs in culture. PICMI displays features characteristic of the
post-implantation epiblast, such as X chromosome inactivation
and high expression of genes of the NODAL/ACTIVIN signaling
pathway (O’Leary et al., 2012).
These and other differences between pluripotent mESCs and
EpiSCs led to the realization of the existence of distinct pluripo-
tent states in vitro (Nichols and Smith, 2009). In a way these
in vitro states are reminiscent of the pluripotency continuum,
which exists within a short time window during early embryogen-
esis (Solter et al., 1970; Stevens, 1970). mESCs resemble early
epiblasts from pre-/peri- implantation embryos and thus exist
in a developmentally earlier or more ‘‘naive’’ state. On the other
hand, EpiSCs were captured and stabilized from egg cylinder
epiblast cells, and thus were exposed to inductive signals
emanating from surrounding tissues, and consequently, are
instructively specified or ‘‘primed’’ for differentiation. The
concept of naive and primed pluripotent states allows distin-
guishing in vitro cultured mESCs and EpiSCs through develop-
mental timing and helps us gain novel insights into the molecular
intricacies underlying developmental regulation of pluripotency
in vivo.
Single-cell analyses demonstrated that mESCs most closely
resemble naive epiblasts of mature E4.5 blastocysts (Boroviak
et al., 2014; Martello and Smith, 2014). Although EpiSCs could
be isolated from pre-gastrulation (E5.5) to late-bud (E8.25)
-stage embryos, they display gene expression profiles more
similar to epiblasts of late-gastrula-stage embryos (Kojima
et al., 2014), suggesting that FGF2/TGFb signaling corralled
post-implantation epiblasts into self-renewal at this stage. These
findings helped pinpoint the in vivo counterparts of mESCs and
EpiSCs and confirmed their existence in two temporally distinct510 Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc.pluripotent states. Apart from their molecular differences, naive
mESCs and primed EpiSCs also differ in their timing ability to
reenter early embryo development. After being injected into
pre-implantation embryos, mESCs could colonize the blastocyst
ICMs and contribute to chimera formation. EpiSCs, however,
were inefficient in being integrated into blastocyst ICMs. Inter-
estingly, chimeric competency of EpiSCs could be robustly
demonstrated after their grafting into post-implantation E7.5 epi-
blasts followed by in vitro whole-embryo culture (Huang et al.,
2012). In contrast, grafted mESCs did not proliferate properly
and failed to differentiate in post-implantation E7.5 epiblasts.
Also, when grafted to embryos of a later developmental stage
(E8.5), by which time pluripotency has been lost, EpiSCs could
not integrate, proliferate, and differentiate. Overall, and in agree-
ment with transcriptomic studies, these observations helped
establish a functional equivalency between mESCs and naive
epiblasts as well as mEpiSCs and late-gastrula-stage epiblasts.
They also highlighted how matching developmental timing is a
key factor for PSCs to colonize and integrate into the developing
embryo.
Conventional hESCs are also classified as primed PSCs.
Although similar, hESCs do exhibit molecular signatures distinct
from EpiSCs (Chia et al., 2010) and after being grafted into E7.5
mouse epiblasts, unlike mEpiSCs, hESCs did not survive for an
extended period of time and failed to proliferate and differentiate
(Wu et al., 2015). This may suggest species differences or they
may represent different types of primed pluripotent states. It is
worth taking into consideration that differences in genetic con-
stituents, as well as post-implantation epiblast morphogenesis
in humans (flattened embryonic disc) and mice (cup-shaped
egg cylinder), may have allowed stabilization of distinct popula-
tions of epiblast cells from different developmental stages upon
exposure to FGF2/TGFb signaling in vitro. In line with this idea,
Bernemann et al. (2011) revealed that EpiSC lines from different
genetic backgrounds displayed features of distinct develop-
mental states. Due to ethical considerations, the exact develop-
mental potential of primed hESCs could not be functionally
evaluated using blastocyst chimeric formation. A supportive
argument for the chimeric-incompetent status of hESCs was
raised by Tachibana et al. (2012) after they demonstrated that
rhesus macaque ESCs propagated in hESC culture could not
colonize rhesus blastocysts and failed in contributing to chimera
formation. Of note is that rhesus ICM explants also failed in their
chimeric contribution capability, but instead could form separate
viable fetuses, presumably due to the formation of independent
hypoblast layers that separated donor and host ICMs. It is thus
unclear from this experiment the relationship between rhesus
ESCs and the in vivo ICM. For conceptual as well as for practical
considerations, finding conditions that can stabilize human
PSCs (hPSCs) in a naive state of pluripotency similar to that of
mESCs is critical (Table 1). It will enrich our understanding of em-
bryonic pluripotency across evolutionarily divergent species, as
well as offer an attractive source of PSCs able to overcome
several practical barriers of conventional primed hESCs,
including low cloning efficiency, limited scalability, and putatively
less amenability for multilineage differentiation.
The first successful attempt at achieving a naive state in
hPSCs relied on continued transgene expression where cells
restored LIF responsiveness and could be propagated in mouse
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cells could not be maintained long-term independent of trans-
gene expression, suggesting that the achieved state was likely
synthetic in nature. A wave of recent reports have claimed the
stabilization of transgene-free naive-like hPSCs (Chan et al.,
2013; Duggal et al., 2015; Gafni et al., 2013; Takashima et al.,
2014; Theunissen et al., 2014; Valamehr et al., 2014; Ware
et al., 2014). Features of mESCs were observed in some of these
naive-like hPSCs, including colony morphology, expression of
naive-related genes, high cloning efficiency, LIF dependency,
and epigenetic and metabolic signatures. It is worth noting that
different human naive cultures vary considerably and many of
them still retain factors that activate FGF/TGFb signaling path-
ways, which are indispensable for maintaining primed pluripo-
tency in mice. This can potentially be attributed to discrepancies
in the ICM’s responses to FGF and NODAL/ACTIVIN signaling
between mouse and human (Blakeley et al., 2015; Kuijk et al.,
2012; Roode et al., 2012). Also, in many cases single-cell
passaging of the naive-like hPSCswas assisted by ROCK kinase
inhibition, a well-adopted strategy to boost the poor cloning ef-
ficiency of primed hPSCs. Thus, it remains unclear whether
these human naive PSCs are the true counterpart of mESCs.
An encouraging study recently claimed a modest chimeric
contribution with naive cynomolgus monkey ESCs converted
from primed cells using a modified human naive culture (Chen
et al., 2015). Although further analyses of live births and germline
contribution are needed to confirm their true naive status, the
possibility of using ESCs for generating chimeric primates is
indeed exciting and may facilitate the generation of non-human
primate (NHP) models (Izpisua Belmonte et al., 2015). Interest-
ingly, Huang et al. (2014) recently took a systems biology
approach and performed weighted gene co-expression network
analysis (WGCNA) of human andmousePSCs.WGCNA revealed
that unlikemurinePSCs, hPSCsexhibit a highdegreeof variation,
likely resulting from distinct culture conditions used by different
studies. More importantly, it was found that naive gene networks
between human and mouse are more divergent than expected
and both showed resemblance to blastocysts of their own spe-
cies origin. This suggests that species-specific pre-implantation
development strategiesmight have imposeddifferent featureson
naive pluripotency.
With the recognition of naive and primed pluripotent states,
our understanding of pluripotency has been temporally enriched.
The ability to capture pluripotency in culture from different time
points provides us with invaluable tools to model early develop-
mental processes in vitro. State transitions between naive and
primed conferred by genetic and epigenetic forces have facili-
tated our molecular understanding of how embryonic pluripo-
tency is harnessed for ensuing proper lineage specification.
Alternative Temporally Distinct Pluripotent States
In addition to naive and primed states, a number of studies have
suggested the existence of other temporally distinct states
(Figure 1 and Table 1).
Post-implantation epiblasts between E5.5 and E6.25 are
competent to form primordial germ cells (PGCs) under inductive
signals from the surrounding extra-embryonic tissues (Ohinata
et al., 2009). PGC competency is largely lost in EpiSCs (Hayashi
and Surani, 2009). A transient cellular state highly similar to thepre-gastrulating epiblast (designated as epiblast-like cells or
EpiLCs) could be generated from naive ESCs (Hayashi et al.,
2011). Unlike EpiSCs, EpiLCs could be efficiently induced to
a PGC fate, thus constituting an ideal startingmaterial for gaining
molecular insights into PGC specification, the first critical step
of germ cell development (Aramaki et al., 2013; Nakaki et al.,
2013). Moreover, robust induction of PGC-like cells (PGC-LCs)
from EpiLCs enables generation of functional gametes using
mESCs and marks the first step in reconstituting complete
germ cell development in vitro, the Holy Grail in mammalian
germ cell biology (Hayashi et al., 2011, 2012). With the arrival
of naive hESCs, a similar strategy has been adopted for the
induction of human PGC-LCs (Irie et al., 2015). Interestingly,
however, a recent report by Sasaki et al. (2015) demonstrated
highly efficient hPGC-LCs induction directly from primed hiPSCs
through an incipient mesoderm-like state (iMeLCs). This obser-
vation suggests that primed hiPSCs bear a property intermediate
between mouse EpiSCs and EpiLCs. In spite of their advan-
tages for germ cell studies, EpiLCs are transient and not a clono-
genic entity.
In another study, Han et al. (2010) identified two cell popula-
tions within EpiSCs that could be distinguished by GFP signals
driven by the entire 18 kb regulatory region of the Oct4 gene
(GOF18). While it is not fully clear why some EpiSCs do not ex-
press the reporter construct, this probably relates to differential
enhancer usages that can be used empirically to define separate
epiblast states. Interestingly, although the Oct4-GFP+ popula-
tion gradually diminished upon extended culture, they could
readily integrate and contribute to chimera formation, contrary
to Oct4-GFP cells, upon blastocyst injection. Germline trans-
mission, however, was not observed with Oct4-GFP+ cells.
From this study it was suggested that a transient population
resembling the early-stage epiblast, and able to retain chimeric
competency, may exist within EpiSC cultures (Gardner et al.,
1985). Indeed, a follow-up study from the same group demon-
strated stabilization of this transient Oct4-GFP+ population
with a modified EpiSC culture condition containing FGF4 (Joo
et al., 2014).
Several other reports have also claimed the isolation of
chimeric-competent EpiSCs, a feature normally associated
with naive ESCs. Chang and Li isolated intermediate epiblast
stem cells (IESCs) displaying dual responsiveness to LIF-
STAT3 and ACTIVIN-SMAD2/3 signaling. IESCs could efficiently
incorporate into the ICM, although they altered further normal
embryo development (Chang and Li, 2013). By introducing
CHIR99021, a GSK3 inhibitor that activates the canonical WNT
pathway and one of the components of ground state 2i culture,
into FGF2/Activin (F/A) EpiSC culture medium, Tsukiyama and
Ohinata (2014) obtained intermediate pluripotent stem cells
(INTPSCs) either from naive ESCs or through reprogramming.
Remarkably, after blastocyst injection, INTPSCs contributed
efficiently to chimeras, including the germline. Gene expression
analysis indicated that INTPSCs retain expression of both naive
and primed specific genes, suggestive of an intermediate plurip-
otent state between ESCs and EpiSCs. Whether INTPSCs
correspond to the natural pre-gastrulating epiblast remains un-
explored. Moreover, it is still unknown whether INTPSCs can
be directly stabilized from post-implantation epiblasts. Intrigu-
ingly, Kurek et al. (2015) recently showed that WNT inhibition,Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc. 511
Table 1. Summary of the Different Flavors of Mouse and Human PSCs and Their Properties
Species States References Culture Condition Features
Mouse totipotent-like Macfarlan et al., 2012 (2C-like) LIF/Serum transient; OCT4/NANOG/
SOX2; MuERV-L+;
embryonic and extra-embryonic
lineage contributions
Morgani et al., 2013 (Hex+ ESCs) 2ia/LIF transient; single Hex+ ESCs co-
expresses epiblast and extra-
embryonic genes; embryonic and
extra-embryonic lineage
contributions
naive Evans and Kaufman, 1981;
Martin, 1981; Smith et al., 1988;
Ying et al., 2003
Serum; LIF/Bmp4 ‘‘dome’’-shaped colony
morphology; high cloning efficiency;
XaXa; germline chimera
Ying et al., 2008 (ground state) 2i ‘‘dome’’-shaped colony
morphology; high cloning efficiency;
XaXa; germline chimera
intermediate Ohinata et al., 2009 (EpiLCs) FGF2/Activin-A/KSR (1%) transient; high PGC induction
efficiency
Han et al., 2010 (Oct4-GFP+
EpiSCs)
FGF2/Actvin-A transient; high ESC reversion
efficiency; gene expression
resembles early epiblast; chimera
without germline contribution
Joo et al., 2014 (FGF4-EpiSCs) FGF4/Serum XaXi; chimera without germline
contribution
Tsukiyama and Ohinata, 2014
(INTPSCs)
FGF2/Activin-A/CH germline chimera
Kurek et al., 2015 (IWP2-EpiSCs) FGF2/Activin-A/IWP2 high ESC reversion efficiency; gene
expression resembles pre-gastrula
epiblast; chimera without germline
contribution
Kim et al., 2013 (CX-EpiSCs) CH/XAV/Serum high cloning efficiency; self-renewal
depends on stabilized cytoplasmic
b-catenin activity
Chang and Li, 2013 (IESCs) Actvin-A/Serum dual responsiveness to LIF-Stat3
and Activin-Smad2/3 signaling;
global gene expression intermediate
between ESCs and EpiSCs; chimera
(low contribution and most show
developmental retardation)
primed Brons et al., 2007; Tesar et al.,
2007 (EpiSCs)
FGF2/Actvin-A ‘‘flattened’’ colony morphology;
XaXi; low cloning efficiency; little to
no blastocyst chimera; broad
engraftment to late epiblast
Wu et al., 2015 (rsEpiSCs) FGF2/IWR1/Serum free high cloning efficiency; short
doubling time; XaXi; no blastocyst
chimera; posterior biased
engraftment to late epiblast
Human heightened Yang et al., 2015 transient treatment with
BAP (BMP4, A83-01 and
PD173074)
insensitive to trypsin passage;
express CDX2; sensitive to high
FGF2 concentration; trophoblast
differentiation in absence of BMP4
treatment
naive Hanna et al., 2010 2i/LIF + DOX
PD/CH/LIF/FK
transgenes-dependent: Klf4/Oct4 or
Klf4/Klf2; ‘‘dome’’-shaped colony
morphology; XaXa; LIF-dependent
and TGF b/Actvin independent
(Continued on next page)
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Table 1. Continued
Species States References Culture Condition Features
Gafni et al., 2013 NHSMb high cloning efficiency; shortened
doubling time; XaXa; DNA
hypomethylation; de novo derivation
from human blastocyst; blastocyst
interspecies embryonic chimerae
Chan et al., 2013 PD/BIO/DOR/LIF LIF-dependent; coexpression of
GATA6 and NANOG
Ware et al., 2014 PD/CH/FGF2 or
PD/CH/SU/LIF
XaXa; de novo derivation from
human blastocyst (low efficiency);
high cloning efficiency; shortened
doubling time; less matured
mitochondria
Theunissen et al., 2014 5iLAc de novo derivation from human
blastocyst; XaXi; elevated and
homogeneous expression of
NANOG, KLF4, and REX1; reduced
level of H3K27me3; no blastocyst
interspecies embryonic chimera
formation
Wang et al., 2014 PD/CH/LIF/FGF2 HERVH+; XaXa; high cloning
efficiency
Takashima et al., 2014
(reset state)
T2ILGOd self-renew independent of ERK
signaling; DNA hypomethylation;
lower levels of H3K27me3 and
H3K9me3; depletion of TFCP2L1 or
KLF4 collapses the reset state;
mitochondrial activation
Duggal et al., 2015 FGF2/LIF/PD/CH/FK/AA high cloning efficiency; reduced
doubling time; XaXa; DNA
hypomethylation
primed Thomson et al., 1998; Reubinoff
et al., 2000; Ludwig et al., 2006
FGF2/KSR; Serum; mTeSR ‘‘flattened’’ colony; XaXi; low cloning
efficiency; little to no blastocyst or
late epiblast interspecies chimeric
contribution
Wu et al., 2015 (rsESCs) F2/IWR1/Serum free high cloning efficiency; XaXi; late-
epiblast interspecific embryonic
chimera
CH, CHIR99021; KSR, Knockout Serum Replacement; XAV, XAV939; DOX, Doxycyclin; PD; PD0325901; FK, Forskolin; DOR, Dorsomorphin; SU,
SU5402; AA, Ascobic Acid; CX, CHIIR99021 and XAV939.
a2i: CHIR99021 and PD0325901.
bNHSM: LIF, TGFb1, FGF2, ERK1/2i (PD0325901), GSK3bi (CHIR99021), JNKi (SP600125) and p38i (SB203580).
c5iLA: LIF, PD0325901, IM-12, SB590885, WH-4-023, Y-27632, Activin-A.
dT2ILGO: LIF, PD0325901, CHIR99021, Go¨6983.
eResults of interspecies embryonic chimera were not reproduced in Theunissen et al.’s 2014 study using either NHSM or 5iLA cultures.
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epiblast state. In this study, a porcupine inhibitor IWP2 that
blocks WNT secretion was used. IWP2-EpiSCs could revert to
naive ESCs with higher efficiency and contribute to chimeric em-
bryo formation. Live chimeras and germline transmission were
not analyzed in this study. These seemingly contradictory obser-
vations can potentially be explained by the intricate role of WNT
signaling in controlling pluripotency. WNT activation promotes
self-renewal of naive ESCs and its inhibition leads to rapid tran-
sition to the primed state (ten Berge et al., 2011). Modulation in
the strength of the Wnt signaling pathway can potentially help
‘‘dial’’ the pluripotency back and forth throughout the earlystages of embryogenesis. Indeed, a combination of a Wnt acti-
vator (CHIR99021) and a Wnt inhibitor (XAV939 or IWR1, but
not IWP2) arrested EpiSCs in a developmental state closer to
ESCs than to EpiSCs grown in conventional F/A culture (Kim
et al., 2013), putatively via a novel cytoplasmic b-catenin activity.
It should also be noted that naive ESCs, particularly under LIF/
Serum culture and primed EpiSCs/hESCs, are heterogeneous
and display sub-states with distinct transcriptional and develop-
mental potentials (Hough et al., 2014; Kumar et al., 2014; Tsakir-
idis et al., 2014). Therefore, other yet-to-be-identified intermedi-
ate states that sit between mESCs and EpiSCs might be
uncovered.Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc. 513
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Figure 1. Spatiotemporally Distinct PSC States
PSCs showing different timing and spatial properties have been isolated from the early mouse embryos. Top: illustrations of mouse embryos at different stages of
early development. Embryonic cells with totipotent or pluripotent potentials are indicated. Bottom: in vitro cultured cells showing functional features resembling
in vivo embryonic cells and categorized into different pluripotent states accordingly. Cell morphologies of mESCs, EpiSCs, and rsEpiSCs are shown.
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the potential to contribute to both embryonic and extra-embry-
onic lineages have been described. In one study, Macfarlan
et al. (2012) identified a rare transient population of mESCs
with embryonic two-cell (2C) -like features that could be identi-
fied by MERV-L retrotransponson expression. These 2C-like
cells lack some key pluripotency proteins, including OCT4,
SOX2, and NANOG, and surprisingly, they acquired the develop-
mental potential reminiscent of totipotency. Remarkably, nearly
all ESCs cycle in and out of this totipotent-like state, a process
partially controlled by histone-modifying enzymes. Induction of
2C-like cells could be facilitated by chromatin reprogramming
through downregulation of the chromatin-assembly activity of
CAF-1 (Ishiuchi et al., 2015). Most recently, however, an in-depth
single-cell RNA-sequencing analysis showed that 2C-like cells
are globally more similar to blastocysts than to two-cell-stage
embryonic cells (Kolodziejczyk et al., 2015). Thus, the true iden-
tity of 2C-like cells remains unclear. In a separate study, Morgani
et al. (2013) found a Hex-positive (Hex is an extra-embryonic
endoderm marker) fraction within ground state mESC cultures
that not only co-expressed epiblast and extra-embryonic marker
genes, but also contributed to both lineages in chimeric em-
bryos. In addition to these rodent studies, hPSCs with height-
ened potency have been also described with transient BMP4
treatment; however, their developmental potential remains
elusive (Yang et al., 2015). The temporal identities of these toti-514 Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc.potent-like states likely precede that of naive ESCs in develop-
mental terms. It remains unknown whether totipotent stem cells
or cells with expanded developmental potentials can be stabi-
lized in culture.
The experimental accessibility of most developmental stages
of mouse embryogenesis has made derivation of pluripotent
cell types from different time points possible. Also, recent
studies have demonstrated that the derived cells are highly plas-
tic and can interconvert in response to extracellular signals (Pera
and Tam, 2010). Although discrete states could be stabilized
in vitro, it should be noted that animal development is a contin-
uous process and temporal states captured in vitro likely only
represent a small group of cells frozen in time in specific cell cul-
ture environments. Future investigations of PSCs with different
timestamps will help delineate the regulatory programs underly-
ing ontogenesis in vivo.
Spatially Distinct Pluripotent States
Animal development is a dynamic process that not only moves
forward in time but also expands in space. Cells at different topo-
logical locations are exposed to diverse external stimuli that,
together with intrinsic cellular cues, lead to specific fate lineage
commitments in the developing embryo. Embryonic cells with
distinct spatial attributes first emerge after the compaction of
eight-cell embryos where an outer polarized epithelial monolayer
encircles a group of inner apolar cells (Stephenson et al., 2012).
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specification: outside cells are committed to form the trophecto-
derm (TE) and the inside cells become the ICM of the blastocyst.
The ICM further segregates into epiblast and primitive endoderm
(PE) lineages with PE facing the blastocoel and epiblast apposed
to the polar trophectoderm. Following implantation into the uter-
ine tissue, the blastocyst goes through a rapid phase of prolifer-
ation and morphogenesis into an elongated cup-like structure,
the egg cylinder. Further into post-implantation development,
the distally positioned epiblast undergoes cavitation and reorga-
nization into an epithelium surrounding a central pro-amniotic
cavity. These morphogenetic events are accompanied by
regionalization and embryonic patterning in preparation for the
subsequent establishment of the whole body plan. It is conceiv-
able that, influenced by local cues, individual epiblast cells bear
distinctive features reflective of their spatial origins.
An in-depth analysis of the grafting outcomes of EpiSCs has
led to the realization that they more readily colonize the anterior
primitive streak of the late-streak-stage embryo (Kojima et al.,
2014). The spatial property of pluripotency became evident after
the recent discovery of a novel class of EpiSCs with distinct
spatial characteristics (Wu et al., 2015). These newly derived
EpiSCswere named region-selective EpiSCs or rsEpiSCs largely
based on their unique ability to selectively engraft into the poste-
rior proximal part of post-implantation epiblast, distinct from
conventional EpiSCs. Following in vitro whole-embryo culture,
grafted rsEpiSCs were able to further proliferate and differentiate
into the three primary germ lineages. In line with this, global tran-
scriptomic comparison of cultured rsEpiSCs with four dissected
regions (anterior-proximal, anterior-distal, posterior-proximal,
and posterior-distal) of the post-implantation epiblasts revealed
a higher correlation between rsEpiSCs with posterior-proximal
epiblast than other epiblast quadrants. Distinct grafting out-
comes and global transcriptome profiles between EpiSCs and
rsEpiSCs allude to the existence of spatially distinct pluripotent
states. Likely other spatially unique pluripotent states may exist
in the post-implantation epiblast, and future studies into this di-
rection will certainly help enrich our understanding of epiblast
patterning and early lineages commitment. In addition to mouse,
rsPSCs have also been obtained from human and rhesus PSCs.
While functional evaluation of human rsPSCs using a post-im-
plantation human epiblast is not possible, grafting human
rsPSCs into a mouse embryo surprisingly resulted in the robust
integration, proliferation, and differentiation of human cells in
the posterior epiblast, a similar outcome to mouse rsEpiSCs.
This suggests that epiblast cells across different species could
be spatiotemporally synchronized in a way that allow human
and mouse cells to intermix during early development.
Xeno-Pluripotency and Interspecies Chimeras
Interspecies approaches, such as mammalian hybrids and het-
erokaryons (Blau et al., 1983), have provided key knowledge
that would have been otherwise impossible to obtain by tradi-
tional means. Interspecies chimera formation is probably the
only ethically acceptable way to study the developmental poten-
tial of hPSCs in an in vivo context. Primed hESCs were first eval-
uated for their xeno-developmental potential following injection
into mouse blastocysts and embryo transfer (James et al.,
2006). In their study, Brivanlou and colleagues found that themajority of human-mouse embryonic chimeras showed develop-
mental retardation and human cells were rarely found inmorpho-
logically normal embryos. A similar finding was reported from a
study using NHP ESCs (Simerly et al., 2011). The presumed
EpiSC-like identity led to the test for grafting hESCs to the
post-implantation mouse epiblast, a permissive environment
for EpiSCs to thrive. Surprisingly, however, hESCs were found
incompatible with the host tissue (Wu et al., 2015). These ob-
servations indicate that primate PSCs grown in conventional
F/A-based media are inefficient in contributing to normal devel-
opment of early mouse embryos (Table 2).
With the advent of naive-like primate PSCs, enthusiasm was
rekindled for examining their interspecies chimeric competency,
or what we refer to here as xeno-pluripotency. The outcomes,
however, are inconsistent. Gafni et al. (2013) reported robust hu-
man-mouse embryonic chimera formation using naive cells
cultured in NHEM medium. In contrast, Theunissen et al. (2014)
did not observe any chimera formation among 860 injected em-
bryos using naive-like hESCs derived in their own 5iLA medium,
or in 436 injected embryos using NHEM cultured naive-like
hESCs previously reported by Gafni et al. To add to the puzzle,
using yet another set of naive culture condition (4i/L/b), Fang
et al. (2014) demonstrated that naive rhesus iPSCs were able
to generate rhesus-mouse chimeric embryos (Table 2). Despite
these seemingly contradicting results, a common observation
that can be drawn from these studies is that naive-like primate
PSCs are more efficient than primed cells in integrating into the
ICM of mouse blastocysts, observations which are supported
by a couple of other studies using reset naive cells (Masaki
et al., 2015; Takashima et al., 2014). It remains an unresolved
issue whether current naive-like hPSCs are able to cross the
xeno-barrier and efficiently contribute to the later developmental
stages of another species. While all of the mentioned studies
used mouse as the host species, since the evolutionary distance
between human and mouse is about 90 million years (http://
www.timetree.org), it will be interesting to test the develop-
mental potential of naive-like hPSCs in animal hosts that are
evolutionarily closer to humans.
Notwithstanding naivety, the xeno-pluripotent property of
primed human rsPSCs to differentiate into all three embryonic
germ lineages in an interspecies chimeric embryo opens a win-
dow of opportunity to study early human developmental events
and understand human versus mouse developmental differ-
ences that are otherwise inaccessible (Table 2). With further
improvement of embryo culture, some remaining questions
could be properly addressed. For example, it remains unknown
to what extent human rsPSCs can differentiate in a developing
mouse embryo. Additionally, it will be important to test whether
such differentiation is efficient enough to enable robust examina-
tion of developmental differences. Alternatively, grafting rsPSCs
in a more accessible model system, such as the developing
chick embryo, and analyzing their fate at desired developmental
stages could potentially help further reveal the xeno-develop-
mental potential of human rsPSCs (Izpisu´a-Belmonte et al.,
1992, 1993; Stern, 2005).
As far as interspecies chimeras are concerned, and due to a
lack of authentic ESCs, earlier work has relied on mixing early
embryos or isolated embryonic cells from two different species
for generating chimeras (Table 2). Initial trials withMus musculusCell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc. 515
Table 2. Summary of the Current State of Research on Interspecies Chimeras
Species
Evolutionary
Distancea Method Surrogate Outcome Reference
Mus musculus,
Myodes glareolus
30.4 Mya morula-morula
aggregation
Mus musculus majority of embryos were
abnormal; two normal-
looking embryos at E9
and E10 with low
chimerism; no live
embryos beyond E11
Mystkowska, 1975
Mus musculus,
Mus caroli
6.5 Mya blastocyst injection
of ICMs
Mus musculus live-born chimeras
developed to adulthood
Rossant and Frels, 1980
Ovis aries, Capra
hircus
9.9 Mya aggregation of four-cell
or eight-cell embryos;
blastocyst injection
of ICMs
Ovis aries or
Capra hircus
live-born chimeras
developed to adulthood
Fehilly et al., 1984
Bos Taurus,
Bos indicus
0.5 Mya aggregation of morulae,
compact morulae or
early blastocyst
demi-embryos
Bos Taurus or
Bos indicus
live-born chimeras
developed to adulthood
Williams et al., 1990
Mus musculus,
Rattus
17.9 Mya morula-morula
aggregation; morula-ICM
aggregation; blastocysts
injection of ICMs
Mus musculus chimeric blastocysts and
embryonic chimeras; no
viable live-born chimeras
Mulnard, 1973; Stern,
1973; Zeilmaker, 1973;
Gardner and Johnson,
1973; Rossant, 1976
blastocyst injection of
rat PSCs
Mus musculus live-born chimeras
developed to adulthood
Kobayashi et al., 2010;
Isotani et al., 2011
blastocyst injection
of mouse PSCs
Rattus live-born chimeras
developed to adulthood
Kobayashi et al., 2010
Mus musculus,
Apodemus sylvaticus
11.4 Mya blastocyst injection of
apodemus ESCs
Mus musculus live-born chimeras
developed to adulthood
Xiang et al., 2008
Mus musculus,
Homo sapiens
90.1 Mya blastocyst injection
of hESCs
Mus musculus developmental
retardation; poor and low
efficient contribution to
normal embryos
James et al., 2006
morula injection of
naive hPSCs
Mus musculus interspecies chimeric
embryos at E8.5–E10.5
(Gafni et al.);
no chimeric contribution
in recovered E10.5
embryos (Theunissen
et al.)
Gafni et al., 2013;
Theunissen et al., 2014
epiblast grafting of
human rsESCs
Mus musculus chimeric contribution
after grafting to posterior
part of E7.5 mouse
epiblast followed by 36 hr
in vitro embryo culture
Wu et al., 2015
Mus musculus,
Macaca mulatta
90.1 Mya eight-cell or blastocyst
injection of rhesus naive
iPSCs
Mus musculus interspecies chimeric
embryos at E10.5
and E16
Fang et al., 2014
ahttp://www.timetree.org.
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and Johnson, 1973; Rossant, 1976; Stern, 1973; Zeilmaker,
1973) and mouse-Myodes glareolus (bank vole) (evolutionary
distance: 30.4 Mya) (Mystkowska, 1975) mostly yielded non-
viable embryos. In 1980 Rossant and Frels reported the first
interspecies chimeras undergoing normal development in mam-
mals (Rossant and Frels, 1980). In this study they used two ro-
dent species: Mus musculus and Mus caroli (ryukyu mouse),
species that are closely related with an evolutionary distance516 Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc.of only about 6.5 Mya. Since then, live chimeras have been
generated between Ovis aries (sheep) and Capra hircus (goat),
9.9 Mya apart (Fehilly et al., 1984); and Bos Taurus (cow) and
Bos indicus (zebu), 0.5 Mya apart (Williams et al., 1990). Of
note is that the pairs of species used in these studies are evolu-
tionarily close in distance, sharing more than 97% of their
genomic sequences. These early studies led to the conclusion
that irreconcilable differences in the course of embryogenesis
precluded formation of viable interspecies chimeras from
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true, the question of how much evolutionary divergence could
be tolerated by pluripotent cells from two species was recently
challenged by the successful generation of live chimeras be-
tween Mus musculus and Apodemus sylvaticus (wood mouse),
which diverged about 11.4 million years ago, a feat achieved
with the use of naive ESCs (Xiang et al., 2008). In addition, live
mouse-rat chimeras were also obtained via injection of naive
mouse or rat PSCs into host rat or mouse blastocysts, respec-
tively, following embryo transfer to surrogates of the host spe-
cies (Kobayashi et al., 2010). These studies suggest that
in vitro cultured rodent PSCs may acquire new features that
allow them to cross xeno-boundaries that are normally not
possible by mixing in vivo embryonic cells. It will be interesting
to see whether this property of cultured PSCs can be further har-
nessed for creating interspecies chimeras of more divergent
evolutionary origins, such as the mouse and bank vole. Also,
de novo derivation of other xeno-pluripotent stem cells (xPSCs)
or artificial pluripotent states created through cellular reprogram-
ing (Tonge et al., 2014; Wu and Izpisua Belmonte, 2014) will offer
further important evolutionary insights.
Engineering-minded approaches may help increase the effi-
ciency and extend the degree of PSCs for crossing xeno-bound-
aries during embryonic development. These approaches will
require a deeper understanding of the molecular and cellular
events unleashed by interspecies cell mixing in early develop-
ment. Two key processes are potentially involved, heterochrony
and cell competition. Heterochrony, a change in the relative
timing or rate of a developmental process, may account for
many of the evolutionary divergences observed. Examining het-
erochrony at genetic, molecular, and cellular levels will help us
understand how development is modified to produce evolu-
tionary changes and explain the inefficiency observed with the
formation of interspecies chimeras (Smith, 2003). Cell-cell
competition, the process of eliminating unfit or unwanted cells,
is gaining increasing recognition as an evolutionarily conserved
mechanism for development, tissue homeostasis, organ size
control, and stem cell maintenance (Claverı´a et al., 2013; John-
ston, 2009). Cell competition was first studied in Drosophila
where cells carrying a Minute mutation were outcompeted by
wild-type cells with metabolic advantages (Morata and Ripoll,
1975). Later studies in mammalian systems revealed that this
process is universal and highly conserved (Amoyel and Bach,
2014). In addition to the classical model, myc-induced super-
competition constitutes another mode of cell competition
whereby cells with higher Myc expression outcompete neigh-
boring wild-type cells (Amoyel and Bach, 2014). Both types of
cell competition have thus far only been examined in the intra-
specific setting and their roles in interspecies chimera formation
await to be explored. Interestingly, by using a genome-wide
cheater screening, Zwaka and colleagues identified a network
of genes whose downregulation confers embryonic cells with
the ability to out-compete wild-type cells in development, a
feature reminiscent of myc-driven super-competition (Dejosez
et al., 2013). Another form of cell competition that is relevant in
an interspecific context is cell cycle differences. Faster dividing
cells from one species will likely dominate and out-compete
slower dividing cells from the other species during development,
affecting the degree of chimerism. Armed with this mechanisticinformation, synthetic biology approaches to program mamma-
lian cell behavior (Lienert et al., 2014) or modulation of cell-cell
competition during early development (Claverı´a et al., 2013)
may expand the repertoire of viable interspecies chimeras and
offer invaluable insights into animal development in an evolu-
tionary context.
The generation of human-animal chimeras, if achieved, will
offer tremendous advantages for regenerative medicine. One
possible application is in vivo drug screening. The current ap-
proaches for drug development include in vitro screening, in vivo
animal models, and eventually multiphase clinical trials in hu-
mans. For in vitro screening patient samples and immortalized
cell lines are conventionally used. Compound screening using
patient samples is limited by their availability and expansion in
culture. Alternatively, immortalized cell lines provide an unlimited
number of cells but their use is often complicated by genetic and
metabolic abnormalities introduced by immortalization. In vivo
transgenic mouse models have been widely adopted for
modeling human diseases and consequently serve as ‘‘in vivo’’
drug screening platforms. However, there are considerable
anatomical, physiological, and behavioral differences between
mice and humans that limit the degree to which insights derived
from the mouse models can be applied to understanding human
biology. The drawback of using animal models has been under-
scored by the failure of translating several successful preclinical
animal tests into human clinical trials. Interspecies chimeras
draw strength from both in vitro human-cell-based screening
and in vivo animal models and hold the potential to be a superior
preclinical testing platform for more accurate prediction of clin-
ical outcomes.
Another future therapeutic application is the potential to obtain
more mature and functional cells, tissues, and even organs from
hPSCs in an in vivo environment. Despite the enormous potential
that has been unleashed by pluripotent hESCs and hiPSCs, cur-
rent in vitro strategies for differentiation to obtain functional and
mature cell types for transplantation have been met with several
major limitations: (1) only limited immature cell types of fetal or
neonatal origin can be produced (Hrvatin et al., 2014) and in
most cases are unsuitable for transplantation (Wu and Hoched-
linger, 2011); (2) differentiation efficiencies vary across cell lines
and often necessitate laborious optimization (Osafune et al.,
2008); (3) differentiating cultures often contain undifferentiated
pluripotent fractions that pose tumor risks; (4) large-scale pro-
duction to meet the clinical demand remains challenging; and
(5) we are still far from generating highly complex tissues and or-
gans in vitro (Lancaster and Knoblich, 2014). Differentiating
hPSCs through the normal course of embryo development in
an in vivo environment of an animal host offers potential solutions
to some of these challenges. Stochastic contribution of donor
PSCs in chimera generation, however, is not ideal for organ gen-
eration, where minimal host cell contamination is imperative.
Interspecies Chimeric Complementation
Throughout evolution, nature has evolved a sophisticated and
robust system to generate functional tissues and organs during
the normal course of embryo development. The intrinsic genetic
program works seamlessly with extrinsic developmental niches
in a highly regulated spatiotemporal manner to enable embry-
onic cells to commit to specific cell lineages and be organizedCell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc. 517
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these developmental principles has been possible thanks to the
powerful combination of gene-targeting technologies with germ-
line competent ESCs for the generation of genome-edited rodent
models. These and other technologies have provided unprece-
dented insights into how specific genetic and epigenetic factors
orchestrate organismal embryonic development. Alterations in
the expression of these factors during embryonic development,
and despite the existence of an intact extrinsic embryonic niche,
leads to tissue and organ impairment, generating in some cases
embryos lacking entire cell lineages and/or organs. To name a
few: homozygous deletion of the Pdx1 gene in mice disables
the pancreatic developmental program and results in the gener-
ation of apancreatic mice that will die soon after birth (Offield
et al., 1996), mouse embryos homozygous for the Lhx1-null
allele lack kidney development, and targeted disruption of the
Nkx2.5 gene in mice leads to embryonic lethality around E10.5
with retarded cardiac development (Lyons et al., 1995).
By genetically disabling organogenesis, the extrinsic develop-
mental niches become ‘‘empty’’ due to the inability of gene-
altered progenitors to populate the embryonic niches. Donor
wild-type PSCs can then be used for the generation of chimeric
animals and to ‘‘fill’’ these empty developmental niches. A
pioneer technique, blastocyst complementation (named so
because donor cells were introduced to the host at the blasto-
cyst stage), was introduced by Alt and colleagues in 1993
(Chen et al., 1993) when they demonstrated that wild-type
mouse ESCs could colonize Rag2/ mouse blastocysts and
generated normal T and B lymphocytes exclusively of donor
origin. For cells other than lymphocytes, Wu et al. (2002) em-
ployed Hprt-deficient blastocyst complementation to derive em-
bryonic fibroblasts from donor mutant ESCs without a selection
marker. This approach is particularly useful for mutations in
donor ESCs that lead to early embryonic lethality. In addition
to cells, organ complementation was first attempted by Douglas
Melton and colleagues in 2007 (Stanger et al., 2007). In this study
they used wild-type mouse ESCs to complement Pdx1-deficient
mouse blastocysts. As a result, the entire pancreatic epithelium
was derived from the donor ESCs. Interestingly, in the same
study, an alternative complementation approach in which condi-
tional progenitor cell ablation based on diphtheria toxin A (DTA)
was used to eliminate PDX1+ pancreatic or LAP+ (liver-enriched
transcriptional activator) hepatic progenitors during develop-
ment and donor ESCs were able to successfully complement
these progenitor deficiencies. For liver, another study by, Espejel
et al. (2010) complemented Fah-deficient blastocysts with wild-
type iPSCs to demonstrate that iPSCs could differentiate into he-
patocytes independent of cell fusion. DTA-based cell ablation
has been used most recently to eliminate NKX2.5+ cardiac pro-
genitors followed by introduction of wild-type ESCs. These wild-
type ESCs were able to successfully compensate for the loss of
progenitors in the developing heart (Sturzu et al., 2015).
Interspecies blastocyst complementation was first suggested
in a study reporting the generation of live mouse-wood mouse
chimeras (Xiang et al., 2008). It was not until 2010 that a mile-
stone paper from Nakauchi’s group (Kobayashi et al., 2010)
demonstrated this potential between mouse and rat. In their
study rat PSCs were used to complement mouse Pdx1 null blas-
tocysts and as a result, an entire rat pancreatic epithelium could518 Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc.be generated in the mouse host. Afterward, Isotani et al. (2011)
successfully complemented blastocysts from nude mice lacking
a thymus with rat ESCs and generated a functional xenogenic rat
thymus. Usui et al. (2012) tried complementing Sal1 null blasto-
cysts to generate kidneys. When mouse PSCs were used, the
kidney was successfully generated via blastocyst complementa-
tion; however, rat iPSCs failed in this context, suggesting that
key molecules involved in the interaction between mesenchyme
and the ureteric buds during kidney development might not be
conserved between mice and rats.
Despite only two successful reports to date, the interspecies
blastocyst complementation platform has raised an intriguing
possibility for the generation of functional human cells/tissues/
organs in animal hosts. Due to its resemblance to humans in
anatomy, physiology, organ size, and cell cycle characteristics,
the pig could be a possible candidate.
With the recent completion of swine genome sequencing
(Groenen et al., 2012), together with the successful development
of SCNT technologies (Lai et al., 2002; Park et al., 2001), the pig
has emerged as one of the most popular large animal models in
biomedical research (Prather et al., 2013). This has been further
enhanced by the advancement of genetic engineering technolo-
gies such as homologous recombination (Lai et al., 2002), zinc
finger nucleases (ZFNs) (Hauschild et al., 2011; Whyte and
Prather, 2012), transcription-activator-like effector nuclease
(TALEN) (Carlson et al., 2012), and the clustered regularly inter-
spaced short palindromic repeats (CRISPR) with RNA-guided
nucleases, such as Cas9 (CRISPR-Cas9) (Hai et al., 2014;
Wang et al., 2015; Whitworth et al., 2014). The combination of
SCNT with genetically modified pig somatic cells has produced
a number of valuable porcine models of human diseases,
including diabetes (Renner et al., 2010; Umeyama et al., 2009),
cystic fibrosis (Rogers et al., 2008), retinitis pigmentosa (Petters
et al., 1997; Ross et al., 2012), spinal muscular atrophy (Lorson
et al., 2011), and Alzheimer’s disease (Kragh et al., 2009). Intra-
specific blastocyst complementation in the pig has also been
achieved by Nakauchi and colleagues (Matsunari et al., 2013).
In their study, the authors cloned fibroblasts overexpressing
HES1 under the Pdx1 promoter. Pdx1-Hes1 transgene expres-
sion suppressed the pancreatic program, thus leading to the cre-
ation of a pancreatogenesis-disabled pig blastocyst. Since
chimeric-competent pig PSCs were not available, the authors
cloned fibroblasts expressing the huKO fluorescent protein
and used blastomeres isolated from huKO embryos to comple-
ment the Pdx1-Hes1 blastocysts. As a result, huKO blastomeres
were able to contribute to chimera formation and generated an
entire huKO+ pancreatic epithelium. Moreover, the chimeric
pigs generated by complementation were able to grow into
adulthood with a functional pancreas.
Despite the success, it is difficult to implement SCNT in a stan-
dard laboratory. With the advent of programmable nucleases
including ZFNs, TALENs, and CAS, genome editing has become
more precise and efficient (Doudna and Charpentier, 2014; Gaj
et al., 2013). These nucleases can recognize specific DNA se-
quences and generate double strand breaks (DSBs) at predeter-
mined genomic loci. Once DSBs are created two major cellular
DSB repair mechanisms (non-homologous end joining [NHEJ]
and homology-directed repair [HDR]) are activated through
which targeted genome modification can be achieved. These
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ing cultured cell lines, but also, more importantly, allow direct
genome editing in early embryos for the fast generation of trans-
genic animals. Error-prone NHEJ produces indels in the genome
that will lead to loss-of-function of genes of interest. A NHEJ-
based knockout strategy is highly efficient and thus has been
successfully achieved in a wide variety of species including
mouse, rat, pig, sheep, cow, and NHP (Geurts et al., 2009; Hai
et al., 2014; Hauschild et al., 2011; Niu et al., 2014; Sung et al.,
2013; Wang et al., 2013). Moreover, the CRISPR-Cas9 system
allows multiplex gene editing, which is advantageous for the
generation of multiple-gene knockouts simultaneously. There-
fore, nuclease-mediated one-cell gene editing is potentially a
more accessible approach for editing host embryos for blasto-
cyst complementation.
As mentioned above, it remains unknown which types of
hPSCs can efficiently cross xeno-barriers. Also it should be
pointed out that there is a larger evolutionary distance between
humans and pigs (95 Mya) than between humans and mice
(90.1 Mya). The choice of pigs as hosts for production of human
organs with hPSCs is rather based on organ size, physiology,
ample supply, and their amenability to be raised in a clean envi-
ronment. From a developmental point of view, however, pigs
have features distinct from both humans and mice which may
be advantageous or disadvantageous; for example: (1) the pres-
ence of porcine ICM lasts for a longer time period (about 6–
7 days) compared to that of mice (1 day) and humans (3 days)
(Oestrup et al., 2009). (2) Both human and pig epiblasts assume
a disk-shaped epiblast layer whereas mice develop a cup-
shaped epiblast. (3) Pigs have epitheliochorial placentae, which
are less invasive than haemochorial placentae typical of humans
and mice. To address the key question of whether hPSCs can
cross species barriers and contribute to early pig development,
it is imperative that hPSCs are empirically tested following injec-
tion into early pig embryos and embryo transfer to pseudopreg-
nant sows. Practically speaking this is not trivial and calls for
collaborative efforts with researchers across many disciplines
including embryologists, veterinarians, stem cell biologists,
genome editing experts, clinicians, and bioethicists. Moreover,
pigs may not be the right host, as currently there is lack of infor-
mation regarding how divergent the developmental programs,
cell-cell communications, signaling for lineage specifications,
and allocations are shared between humans and pigs. In addi-
tion to pigs, we also need to consider other animal species
such as sheep (95 Mya), goat (95 Mya), cow (95 Mya), and rabbit
(90.1Mya), among others. Evolutionarily closer NHPs (e.g., com-
mon marmoset, 41.8 Mya; rhesus macaque, 27.3 Mya; Chimp,
6.2 Mya), however, are unlikely to be considered due to practical
and ethical reasons.
In addition to blastocyst complementation, there are other
forms of chimeric complementation (Figure 2): (1) tetraploid
complementation, the most stringent in vivo pluripotency test,
is probably the ultimate chimeric complementation with donor
ESCs contributing to all structures in the fetus (Nagy et al.,
1993). It will be intriguing to know whether this can work in an
interspecies scenario where PSCs from one species can
generate an entire living organism inside the tetraploid embryo
of another species. (2) Since human rsPSCs can be incorporated
and differentiated in the epiblast of gastrula mouse embryos,interspecies epiblast complementation may help enrich human
cells in early peri-gastrula developmental niches and generate
early human progenitor cells. (3) In utero conceptus complemen-
tation with human lineage progenitors offers an alternative way
to generate human organs in organogenesis-disabled livestock
(Rashid et al., 2014). Previous studies on grafting human primary
cells, or cell derivatives generated from hPSCs, to a wide variety
of experimental animals have paved the way for gaining impor-
tant insights into key parameters—among them, the cellular
and molecular host niche environment, cross-species signaling
interplays, and developmentally permissive spatiotemporal attri-
butes—that are important for successful human cell engrafting
following in utero injection (Fisher et al., 2013; Nicholas et al.,
2013; Si-Tayeb et al., 2010; Zhang et al., 2001).
Ethical Considerations
The isolation of different types of hPSCs and their potential to
contribute to interspecies chimera formation have, on one
hand, opened new avenues to study human biology and unveil
novel regenerative medicine applications; on the other hand,
however, they also unleash new ethical challenges. Human-ani-
mal chimera research involves the transfer of totipotent, pluripo-
tent, ormulti-potent stem cells or their derivatives, into animals in
embryonic, fetal, or postnatal stages of development (Hyun
et al., 2007). According to this definition, teratoma assays, the
grafting of pluripotent hPSCs into immunodeficient animals
(mouse prevalently) to evaluate their in vivo differentiation poten-
tial, can be considered as one type of human-animal chimera
(Lensch et al., 2007). Teratomas are generated heterotopically
and thus pose different ethical issues compared to chimeras
created via mixing cells at the pre-implantation blastocyst stage
of development. Orthotopic human-animal chimeric embryos
generated by integrating human cells into different develop-
mental stages of animal embryos also have different ethical im-
plications and should be evaluated case by case.
From an ethical perspective, three main categories of ortho-
topic human-animal chimera research need to be considered
(Hermere´n, 2015; Hyun, 2015). One involves in vitro studies using
early embryos. A case in point is the implantation of human
rsPSCs into isolated early post-implantationmouse embryos fol-
lowed by short-term in vitro culture (Wu et al., 2015). Since with
current technologies the chimeric embryos generated are non-
viable and cannot be carried to term, there are minimal concerns
of animal health andwelfare aswell as ethical issues. The second
involves the generation of in vivo embryonic chimeras. Chimeras
generated with naive hPSCs by Hanna’s group fall into this cate-
gory (Gafni et al., 2013). In their experimental set up, pregnancy
was stopped 10 days into mouse gestation, a period within the
limit allowed for research on human embryos (Hermere´n,
2015). Although it is possible that the fetal mouse brain might
have had some degree of human contribution, ethical concerns
are in this case limited. The third category includes in vivo studies
with sentient animals, which raises additional ethical challenges
(Hermere´n, 2015). Although no hPSCs have been reported,
multi-potent stem cells and their derivatives are commonly being
injected into live animals including NHPs for evaluation of their
differentiation potential or function (Kriks et al., 2011; Pagliuca
et al., 2014; Zhu et al., 2014). In a study by Goldman and col-
laborators in 2013, mouse forebrain glial cells were replacedCell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc. 519
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Figure 2. Interspecies Chimeric Complementation
By genetically altering the host embryos (e.g., Pdx1/), developmental programs specific for certain lineages and organs can be disabled. Totipotent, plurip-
otent, or multi-potent stem cells from one species can potentially be used to rescue the organ defects of the host species at different time points during
development. And as a result, organs enriched with cells derived from donor stem cells are generated in a xeno environment.
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elevated cognitive capability with enhanced plasticity and
learning, and thus raised the question of whether moral human-
ization accompanys biological humanization in these chimeras,
a concept not readily accommodated by existing ethical guide-
lines (Hyun, 2015).
Human tissue and organ generation using animal hosts needs
to be approached with the appropriate precautions. Guidelines
on human-animal chimeras put forward by theNational Academy
of Sciences (NAS) (National Research Council, 2005; National
Research Council, 2007) and the International Society for Stem
Cell Research (ISSCR) (http://www.isscr.org/docs/default-source/
hesc-guidelines/isscrhescguidelines2006.pdf) should be strictly
followed. Both guidelines made the following recommendation:
‘‘All research involving the introduction of hES cells into
nonhuman animals at any stage of embryonic, fetal, or postnatal
development should be reviewed by the ESCRO committee.
Particular attention should bepaid to the probable pattern and ef-
fects of differentiation and integration of the human cells into the
nonhuman animal tissues.’’ TheNASand ISSCRalso recommen-520 Cell Stem Cell 17, November 5, 2015 ª2015 Elsevier Inc.ded limits on interspecies chimera research involving human
cells. Currently, it is commonly agreed that no hPSCs should be
allowed to be implanted in NHP embryos and that human-animal
chimeras should not be allowed to breed. Current NIH funding
guidelines follow these recommendations and prohibit experi-
ments on breeding human-animal chimeras and mixing hPSCs
with NHP embryos. These recommendations, however, do not
preclude injecting hPSCs into early embryos of other species,
such as the pig. Most recently, on September 23, 2015, the NIH
issued a notice stating that research in which hPSCs are intro-
duced into non-human vertebrate animal pre-gastrulation stage
embryoswill not be fundedwhile the agency considers a possible
policy revision in this area (https://grants.nih.gov/grants/guide/
notice-files/NOT-OD-15-158.html). The NIH has invited scien-
tists and bioethicists to aworkshop onNovember 6, 2015 to eval-
uate the state of scientific and ethical issues in animal-human
chimera research and a revised guideline is expected to be in
place afterward.
Strategies to ease some of the ethical concerns, especially
those related to brain contributions, can be envisioned: due to
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Perspectivemarked differences in differentiation bias among hPSC lines
(Osafune et al., 2008), selecting lines that are inefficient for neural
differentiation could be considered. It has been proposed that
modulation of certain lineage transcription factors can influence
PSCs’ in vivo differentiation propensity (Kobayashi et al., 2015),
thus offering a path for avoiding neural contribution. Other
methods that could be worth considering include genetic inacti-
vation of key genes for human neural development (Zhang et al.,
2010) and/or implementation of safety switches similar to what
has been used for adoptive T cell therapy, which can trigger
apoptosis in hPSC-derived neurons (Di Stasi et al., 2011; Straa-
thof et al., 2005).Conclusion
We have come a long way since the first capture of embryonic
pluripotency in culture. The derivation of mESCs has trans-
formed modern biology. Their abilities to indefinitely expand
in vitro and generate all adult lineages in vivo, combined with
gene editing technologies, have provided us with a vast treasure
of human disease models. The quest for understanding extrinsic
and intrinsic cues underlying pluripotency has contributed to the
recent isolation of various spatiotemporally divergent pluripotent
states. Chimeric competency is no longer a privilege of mESCs.
Naive ESCs capable of contributing to germline chimeras have
been derived from other rodents and most recently from the
cynomolgus monkey. Chimeric competency has also been
expanded into the realm of interspecies with naive ESCs effi-
ciently crossing xeno-boundaries among rodents for the gener-
ation of live interspecies chimeras. The discovery of a spectrum
of pluripotent states across intra- and inter-species domains will
open new avenues for uncovering novel and thought-provoking
areas of investigation in embryonic development, pathogenesis,
aging, and evolution.
These advances in animal models go hand in hand with the
rapidly evolving field of hPSCs and regenerative medicine.
hPSCs hold great potential to revolutionize the practice of med-
icine since they constitute the source fromwhere unlimited cells,
tissues, or even organs could be derived to treat numerous debil-
itating disorders. Despite substantial progress, to date, no
hPSC-based therapies have transitioned from experimental to
clinical practice. Infused with novel concepts in pluripotency
and equipped with the unique properties of naive and region-
specific hPSCs, regenerative medicine applications unlocking
the full potential of hPSCs can be envisioned. Empowered by
interspecies chimeric-competent rsPSCs, naive hPSCs, or other
novel PSC types, complex tissue and organ generation may, in a
not too distant future, become feasible.ACKNOWLEDGMENTS
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